N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide

C25H26F2N8O3S — CID 164547442

IUPACN-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide
SMILESCOCCn1cc(-c2cn3nc4c5ncc(C(=O)NCCN6CCC(F)(F)CC6)cc5[nH]c(=O)c4c3s2)cn1
InChIInChI=1S/C25H26F2N8O3S/c1-38-9-8-34-13-16(12-30-34)18-14-35-24(39-18)19-21(32-35)20-17(31-23(19)37)10-15(11-29-20)22(36)28-4-7-33-5-2-25(26,27)3-6-33/h10-14H,2-9H2,1H3,(H,28,36)(H,31,37)
InChIKeyKLKSZAIZJZOGKW-UHFFFAOYSA-N
MW556.60 g/mol
LogP2.76
Rot. Bonds8

About N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide

N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide (PubChem CID 164547442) has the molecular formula C25H26F2N8O3S and a molecular weight of 556.60 g/mol. Its IUPAC name is N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide.

Molecular Properties

Compound NameN-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide
PubChem CID164547442
Molecular FormulaC25H26F2N8O3S
Molecular Weight556.60 g/mol
Exact Mass556.18
IUPAC NameN-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide
SMILESCOCCn1cc(-c2cn3nc4c5ncc(C(=O)NCCN6CCC(F)(F)CC6)cc5[nH]c(=O)c4c3s2)cn1
InChIInChI=1S/C25H26F2N8O3S/c1-38-9-8-34-13-16(12-30-34)18-14-35-24(39-18)19-21(32-35)20-17(31-23(19)37)10-15(11-29-20)22(36)28-4-7-33-5-2-25(26,27)3-6-33/h10-14H,2-9H2,1H3,(H,28,36)(H,31,37)
InChIKeyKLKSZAIZJZOGKW-UHFFFAOYSA-N
XLogP2.76
TPSA122.44 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds8
Heavy Atoms39
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500556.60
LogP ≤ 52.76
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide?
The IUPAC name of N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide (CID 164547442) is N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide.
What is the SMILES notation for N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide?
The canonical SMILES for N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide is COCCn1cc(-c2cn3nc4c5ncc(C(=O)NCCN6CCC(F)(F)CC6)cc5[nH]c(=O)c4c3s2)cn1.
What is the InChIKey of N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide?
The InChIKey is KLKSZAIZJZOGKW-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26F2N8O3S/c1-38-9-8-34-13-16(12-30-34)18-14-35-24(39-18)19-21(32-35)20-17(31-23(19)37)10-15(11-29-20)22(36)28-4-7-33-5-2-25(26,27)3-6-33/h10-14H,2-9H2,1H3,(H,28,36)(H,31,37).
What are the key properties of N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide?
N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide has a molecular weight of 556.60 g/mol, XLogP of 2.76, 8 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-13-[1-(2-methoxyethyl)pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide is sourced from PubChem (CID 164547442), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).